Scarica l'app Stockscreener
0.8866
1.64%
-0.0148
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Neuroone Medical Technologies Corp Borsa (NMTC) Ultime notizie
How volatile is NeuroOne Medical Technologies Corporation stock compared to the marketIdentify breakout stocks before they peak - jammulinksnews.com
NeuroOne Medical Technologies Corporation Stock Chart Analysis: Bullish or Bearish Pattern FormingHigh Accuracy Alerts - Newser
What are NeuroOne Medical Technologies Corporation company’s key revenue driversTriple-digit wealth increases - jammulinksnews.com
Does NeuroOne Medical Technologies Corporation stock perform well during market downturnsTrack high-yield stocks before they peak - jammulinksnews.com
Critical Contrast: So-Young International (NASDAQ:SY) vs. NeuroOne Medical Technologies (NASDAQ:NMTC) - Defense World
What makes NeuroOne Medical Technologies Corporation stock price move sharplyVerified Return Tips - Newser
What drives NeuroOne Medical Technologies Corporation stock priceOverwhelming financial success - Autocar Professional
NeuroOne receives USPTO patent allowance for neural probe technology By Investing.com - Investing.com Nigeria
NeuroOne Medical Technologies Secures Notice of Allowance for Key Neural Probe Patent - Quiver Quantitative
NeuroOne receives patent allowance for neural probe technology - Investing.com
NeuroOne Strengthens Neural Tech Leadership with Strategic USPTO Patent for Advanced Electrode Technology - Stock Titan
What analysts say about NeuroOne Medical Technologies Corporation stockOverwhelming profit margins - Autocar Professional
Is NeuroOne Medical Technologies Corporation a good long term investmentBreakout profit opportunities - jammulinksnews.com
NeuroOne Medical Technologies Corporation Stock Analysis and ForecastAccelerated investment success - jammulinksnews.com
81,000 Shares in NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Bought by Cambridge Investment Research Advisors Inc. - Defense World
Why NeuroOne Medical Technologies Corporation stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
How NeuroOne Medical Technologies Corporation stock performs during market volatilityHigh Return Intraday Picks - Newser
Revolutionary OneRF Treatment Transforms Patient's Life: From 10 Daily Seizures to Complete Freedom for 1 Year - Stock Titan
Certain Warrants of NeuroOne Medical Technologies Corporation are subject to a Lock-Up Agreement Ending on 19-JUN-2025. - MarketScreener
Certain Common Stock of NeuroOne Medical Technologies Corporation are subject to a Lock-Up Agreement Ending on 19-JUN-2025. - MarketScreener
Jane Street Group LLC Takes $33,000 Position in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) - Defense World
NeuroOne Medical (NMTC) Enhances Leadership with New General Cou - GuruFocus
NeuroOne Cuts Legal Costs with Strategic General Counsel Hire: Former Partner Joins Executive Team - Stock Titan
NeuroOne CEO to Meet Investors at MedInvest Conference: Spotlight on Neural Surgery Innovation - Stock Titan
NeuroOne Medical Technologies (NASDAQ:NMTC) Trading 1.1% Higher – Should You Buy? - Defense World
NeuroOne Completes FDA Submission for OneRF Trigeminal Nerve Ablation System - Medical Product Outsourcing
NeuroOne Medical Technologies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
NMTC Achieves Growth in Q2 with Advancements in OneRF Technology - GuruFocus
Earnings call transcript: NeuroOne Medical beats EPS expectations in Q1 2025 - Investing.com Canada
NeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call Highlights: Revenue Surge and ... - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call - GuruFocus
NeuroOne Medical Technologies Corp Reports Q2 FY2025 Earnings: E - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6% - Stock Titan
NeuroOne Medical (NMTC) Welcomes New Chief Medical Advisor | NMT - GuruFocus
NeuroOne Medical Technologies (NMTC) Appoints New Chief Medical Advisor - GuruFocus
NeuroOne appoints Dr. Patil as Chief Medical Advisor - Investing.com
NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor - Stock Titan
NeuroOne Medical Opens Exclusive Investor Access: CFO Hosts One-on-One Meetings at Plaza Hotel - Stock Titan
NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
NeuroOne Medical Tech (NMTC) Coverage Initiated by Ladenburg Tha - GuruFocus
This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Geode Capital Management LLC Grows Stake in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) - Defense World
NeuroOne Earnings: Medical Tech Leader to Reveal Q2 2025 Growth Strategy and Financial Results - Stock Titan
NeuroOne Medical Technologies Corp [NMTC] Records 50-Day SMA of $0.8911 - knoxdaily.com
NeuroOne Medical Technologies Corp’s results are impressive - uspostnews.com
The Future of NeuroOne Medical Technologies Corp: Analyzing NMTC - investchronicle.com
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigemina - GuruFocus
1.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):